Powerhouse Ventures Limited Overview
Powerhouse Ventures is a Brisbane-based micro-cap merchant bank and specialist investment house that has spent the past three years converting itself from a loss-making New Zealand university-IP incubator into a fee-earning financial services group. It now runs three client-facing business lines — Corporate Advisory (equity capital markets, IPOs, structured debt, M&A for ASX micro-caps), Funds Management (the Aliwa Alpha Fund and the Critical Infrastructure Opportunities Fund) and, from October 2026, Powerhouse Venture Partners (business-building for critical-technology companies) — supported by a Treasury unit that manages a ~$19m portfolio of listed and unlisted holdings. Its defining "merchant capital" model co-invests balance-sheet and fund capital alongside the capital it raises for clients. FY2026 delivered $3.89m of fee revenue (+344%), a maiden company-defined operating profit of $0.8m, NPAT of $1.25m and zero debt. Scale, governance depth and earnings volatility remain the central investment questions.
Company's own description (latest annual report, paraphrased)
In its FY2026 Annual Report the company describes itself as a high-conviction speciality investment house with an expanding range of funds management products, advisory and capital syndication services and investor relations support. It states that it targets asset classes it considers temporarily dislocated, under-appreciated or at the "next frontier" of growth, with high conviction on listed small caps, Australian carbon projects, and technologies expected to become critical infrastructure [S1]. The Executive Chairman frames FY2025 as the "foundational" year and FY2026 as the "confirmation" year of the model, emphasising that recurring, client-generated revenue rose to 58.1% of total revenue from 16.5% a year earlier, while reliance on unrealised movements in unlisted holdings fell from 53.1% to 16.2% [S1].
Independent characterisation
Powerhouse is best understood as a listed micro-cap merchant bank with an embedded closed-end investment portfolio. Economically it has three engines:
-
Fee engine (Advisory + Funds). Advisory earns mandate retainers, success fees on capital raisings, corporate brokerage and AFSL/corporate-authorised-representative fees. Funds Management earns management and performance fees on wholesale funds. Together these produced $3.89m of revenue from contracts with customers in FY2026, against $0.88m in FY2025 and effectively nil ($2,449) in FY2024 [S1][S2].
-
Principal investment engine (Treasury/Investing). The group holds an $18.95m fair-valued portfolio (30 Jun 2026) of ASX-listed micro-caps, unlisted deep-tech companies, options, SAFE notes and treasury bonds [S1]. Gains are recognised through profit or loss under AASB 9 and are inherently volatile.
-
Scrip-to-cash recycling loop ("Value Flywheel"). Advisory fees are frequently taken in client scrip — 53% of Advisory revenue in FY2026 was received or earned in scrip [S3]. Those holdings sit in Treasury and are recycled into cash as they appreciate; the group recycled more than $1.4m of ASX-listed positions in FY2026 for a $433k realised gain [S1].
Revenue model mix [S1]
| Revenue stream | Type | FY2026 (AUD Mn) | Share of total (%) |
|---|---|---|---|
| Success fees | Transactional service | 2.468 | 36.9 |
| Management fees | Recurring (FUM-linked) | 0.451 | 6.7 |
| Mandate fees | Retainer service | 0.445 | 6.6 |
| Corporate brokerage fees | Transactional service | 0.305 | 4.6 |
| Performance fees | Variable (fund performance) | 0.142 | 2.1 |
| AFSL fees | Recurring licensing/CAR service | 0.076 | 1.1 |
| Net realised/unrealised investment gains | Principal investing | 2.784 | 41.6 |
| Interest revenue | Treasury | 0.021 | 0.3 |
| Total | — | 6.692 | 100.0 |
No subscription or product revenue exists; there is no licensing of intellectual property despite the company's history as an IP commercialisation vehicle.
Value-chain position, customers and end-markets
| Dimension | Description |
|---|---|
| Value-chain position | Intermediary between private/wholesale capital and ASX micro-cap/pre-IPO issuers; principal co-investor; fund sponsor and manager |
| Customer types | ASX-listed micro/small caps (typically under ~$250m market cap per aggregator description), pre-IPO companies, emerging critical-tech companies, wholesale/sophisticated investors (fund unitholders), family offices and institutional co-investors |
| End-markets (issuer sectors) | Resources (gold, silver, graphite, critical minerals, energy), advanced manufacturing (metal additive), space, quantum computing/cybersecurity, AI, advanced materials, biotech/healthtech, carbon |
| Geography | Operations in Australia; investments also in New Zealand and the United States; PVP network referencing US, Europe, Korea and Japan |
| Concentration | No single customer above 10% of trading revenue (FY2025 and FY2026) [S1][S2] |
Strategy
Stated strategy (themes from FY2025–FY2026 Annual Reports)
The company repeatedly anchors strategy in a "merchant capital model" in which it invests alongside the capital it raises — what the Chairman calls putting "our money where our mouth is" [S2]. It applies four high-conviction selection criteria: (1) asset classes with a strong macro thematic and deep in-house knowledge; (2) aligned and experienced management teams; (3) asymmetric, upside-skewed return profiles; and (4) clearly defined re-rating catalysts [S1]. The investment policy explicitly favours shorter-duration, more liquid assets (ASX Level 1 and 2 securities) to fund operations by recycling capital rather than raising equity [S1][S2]. The proposed rename to Powerhouse Capital Partners is presented as signalling an institutional-quality co-investment partner rather than a venture-stage entity [S10].
Strategic initiatives — last 24 months
| Date | Initiative | Type | Detail / targets | Status |
|---|---|---|---|---|
| Sep–Dec 2024 | Acquire New River (AFSL), Informed Investor, Aliwa Funds Management | Platform build (M&A) | All-scrip; internalises licensing, investor engagement, funds | Complete |
| Jan 2025 | Three-segment operating model | Restructuring | Advisory, Funds, Investing/Treasury | Complete |
| Feb 2025 | Launch Powerhouse Advisory Australia under Richard Rouse | New business | ECM/M&A advisory | Operating; >$40m transaction value FY2026 |
| Mar 2025 | Burleigh Ventures unlisted tech fund initiative | New product | Originally framed as ~$20m combined seed ($9m PVL + ~$5m Aliwa private positions + others) [S22] | Superseded by CIO Fund |
| Jul 2025 | RegenEarth Group Pty Ltd registered | New subsidiary | Purpose not disclosed; likely carbon theme (unconfirmed) | Registered |
| Sep 2025 | Final pre-fund investments in quantum and AI | Portfolio | Positions to transfer at par into CIO Fund for units [S24] | Complete |
| Dec 2025 | Strategic partnership for Burleigh fund | Partnership | Financial and operational support, capital introductions, idea generation; cloud-infrastructure focus [S23] | Announced |
| Q3 FY2026 | AI-enabled scalable operating platform | Platform investment | Build-out accelerated [S7] | In progress; spend not disclosed |
| Apr 2026 | Rename to Powerhouse Capital Partners Limited | Brand | Requires 75% special resolution; PVL code retained [S10] | — |
| May 2026 | Critical Infrastructure Opportunities Fund (CCIV) | New product | ~$13m seed (11 positions); $75m raise target; ~20% p.a. IRR target; TRL 7–9 [S8] | Launched; raising |
| Jun 2026 | MOU with European venture firm | Partnership/new product | Global co-managed tech fund, ~$100m target commitments [S3][S28] | MOU |
| Jul 2026 | Aliwa Alpha Fund capital raising | Growth | Soft-close targeted during FY2027; management aiming for +$5m external FUM in FY2027 [S27][S1] | Underway |
| Oct 2026 | Powerhouse Venture Partners as third client-facing unit; SPV1 – Dual-Use Technologies | New business | Noosa Partners collaboration; CCIV products [S9] | Launched |
Management targets / guidance
| Item | Target / statement | Source |
|---|---|---|
| CIO Fund | $75m new capital; ~20% p.a. portfolio IRR | S8 |
| Aliwa FUM | Raise additional ~$5m externally in FY2027; goodwill model assumes FUM growth 15% p.a. in years 1–2 | S1 |
| European global fund | ~$100m commitments; launch CY2026 | S3 |
| Q2 FY2026 outlook | Expected "material profit increase" on FY2025 (not achieved at NPAT level; achieved at operating-profit level) | S6, S1 |
| FY2027 | Results release references "four priorities" for FY2027 | S3 |
| ESG/cost programs | None disclosed | — |
No formal quantitative earnings guidance has been issued. Disclosed targets and expectations:
Products & Services
Advisory (Powerhouse Advisory Australia)
| Offering | Description / capabilities | Target customer | Launch | Pricing model | Flagship evidence |
|---|---|---|---|---|---|
| Secondary equity raisings (placements) | Lead/co-lead manager; investor distribution through PVL's wholesale network; co-investment by Treasury and/or Funds | ASX micro/small caps | Inaugural quarter Q4 FY2025 | Success fee (cash and/or scrip), corporate brokerage fee | 10 mandates and >$40m transaction value completed in FY2026; 7 of 8 ECM transactions trading at/above issue price at 25 Aug 2026, with an equal-weighted annualised ECM return of 62.7% [S3] |
| IPOs and relistings | Pre-IPO structuring, listing execution | Pre-IPO companies | FY2026 (first IPO mandate) | Success fee, mandate fee | One IPO among FY2026 mandates [S3]; Metal Powder Works relisting (Mar 2025) [S2] |
| Structured debt | Arranging debt instruments | Listed issuers | FY2026 | Success/arrangement fee | Included in FY2026 mandate mix [S3] |
| Sell-side M&A | Transaction advisory | Listed/private companies | FY2026 (first engagement) | Success fee | First sell-side M&A engagement in FY2026 [S3] |
| Corporate retainers | Monthly retained capital-markets strategy and commercial support | Listed micro-caps | FY2025 | Monthly mandate fee | $0.445m mandate fees FY2026 [S1]; 10 active mandates at 31 Mar 2026 [S7] |
| AFSL / authorised representative services | Licensing services via New River AFSL 497505 | Advisers/managers needing licence coverage | Acquired Sep 2024 | Fixed fees | $76k AFSL fees FY2026 [S1] |
Named FY2025–FY2026 advisory/co-investment clients in filings and coverage include Nordic Resources (NNL), Metal Powder Works (MPW), Site Group International (SIT), Desert Mining (DSM), Pivotal Metals, Greenwing, Sarama Resources, Variscan Mining, Peak Processing, Pilot Energy and Janus Electric (inferred from scrip/option holdings in the FY2026 portfolio list) [S1]. An aggregator summary attributes a $3.5m NNL placement (+55% share price), a $2.7m SRR raise (+33%) and a reverse merger for MPW (~15x uplift) to the Advisory unit.
Funds Management
| Product | Structure | Strategy | Launch / status | Pricing | Key data |
|---|---|---|---|---|---|
| Aliwa Alpha Fund | Wholesale unit trust (manager: Aliwa Funds Management) | Long-biased ASX micro/small-cap equities | Pre-dates acquisition (~7-year record referenced); acquired Dec 2024 | Management fee (% of FUM) and performance fee above hurdle with high-water mark; exact rates not publicly disclosed | FUM ~$31.5m at 30 Jun 2026; FY2026 net return 34.73% vs benchmark 7.53%; annualised 20.88% since inception; ranked 2nd of 100 in FundMonitors.com Equity Long Small/Mid-Cap Australia peer group [S3][S1]. High-water mark reset 1 Apr 2026 [S1] |
| Critical Infrastructure Opportunities Fund (CIO Fund) | Sub-fund of a Corporate Collective Investment Vehicle (CCIV) under Ch. 8B Corporations Act; manager Powerhouse Venture Partners | Late-stage private tech (Technology Readiness Level 7–9) across Space, Quantum, AI, Advanced Materials | Launched 6 May 2026; wholesale only | Fees not publicly disclosed; target portfolio IRR ~20% p.a. | ~$13m seed across 11 positions (incl. Southern Launch, Skykraft, Quantinuum per media); $75m new-capital target, ~30% expected from team and partner GlobalDots [S8] |
| SPV1 – Dual-Use Technologies | CCIV-based thematic wholesale product (PVP) | Australian dual-use tech: sensing, course-of-action AI, battery supply chain, generative instrumentation | Announced 8 Oct 2026 "to launch shortly" | — | No size, timing or return targets disclosed [S9] |
| Global technology fund (with European venture firm) | Co-managed fund (MOU stage) | Space, Quantum, AI, Advanced Materials | MOU signed ~Jun 2026; launch planned CY2026/FY2027 | — | Target ~$100m total commitments (S3 states ~$100m; S28 headline states USD100m — currency discrepancy unresolved) |
Powerhouse Venture Partners (business-building unit, from Oct 2026) [S9]
| Building block | Services |
|---|---|
| Commercial | Product-market fit, paid proofs of concept, offtake agreements |
| Corporate | Company structuring, governance, liquidity and listing strategy |
| Capital | Capital strategy aligned to value inflection points, sovereign/institutional register building, founder exits |
| Network | Industry experts in US, Europe, Korea, Japan; access to US/NATO defence primes, Korean/Japanese OEMs and trading houses |
| Partner | Noosa Partners (Michael Datta joins as Strategic Growth Partner; Noosa chaired by The Hon. Arthur Sinodinos AO) |
Investing / Treasury — portfolio holdings at 30 June 2026 [S1]
| Level | Holdings | Fair value (AUD Mn) |
|---|---|---|
| Level 1 (quoted) | Metal Powder Works, Janus Electric Holdings, GF Asset Management (NAV), Nordic Resources, Triangle Energy, Pivotal Metals, 6K Additive Inc, AI-Media Technologies, Invion listed options | 3.869 |
| Level 2 (recent pricing event / Black-Scholes) | Inhibit Coatings, Ferronova, Skykraft, Neuroflex, Allied Graphite, Liquid Instruments, Si-Ga Data Security, Southern Launch, Carbonaught, VeriQuantix, Sirius Beta Labs, Aqur BioSciences; unlisted options in Intelicare, Janus Electric, Pilot Energy, Nordic Resources, Variscan, Sarama, Pivotal Metals, Desert Mining, Greenwing, Peak Processing | 9.022 |
| Level 3 (model-based) | Veritide, Cirrus Materials, Quantum Brilliance, Flomatrix, Revaia, Earthbanc | 6.063 |
| Total | — | 18.955 |
| Instrument type (AUD M) | FY2025 | FY2026 |
| ASX-listed equity securities (AUD M) | 2.321 | 3.378 |
| Unlisted options (AUD M) | 0.143 | 1.314 |
| Unlisted equity securities (AUD M) | 10.594 | 13.414 |
| Treasury bonds (AUD M) | 0.314 | 0.490 |
| Cryptocurrencies (AUD M) | 0.122 | 0 |
| Convertible notes (AUD M) | 0.157 | 0 |
| SAFE notes (AUD M) | 0.659 | 0.359 |
| Total (AUD M) | 14.309 | 18.955 |
Notable FY2026 new investments: VeriQuantix (quantum-based fibre eavesdropping detection; $295k first tranche, ~$205k follow-on due ~Oct 2026), Sirius Beta Labs (situated-reasoning AI for dual-use; $250k), Aqur BioSciences (US oral cholesterol-lowering drug; US$200k), Inhibit Coatings follow-on ($73k), Electriq Global SAFE note ($100k) [S1].
Informed Investor (media/investor engagement)
Website domain and business acquired from Sequoia Financial Group (Sep 2024) for 2m PVL shares; PVL stated it would pivot content toward its funds and advisory activities and that the site could continue to draw on Sequoia's existing arrangements [S11]. Revenue contribution not separately disclosed. Customer-list intangible ($252k cost, 3-year life) relates to the acquisitions [S1].
Financial Narrative
Income statement
Additional data points: FY2021 loss of $1.465m [S2]; derived basic EPS FY2022 approx. -0.24c and FY2023 approx. 0.59c (NPAT ÷ ~120.74m shares; analyst calculation). The company's non-IFRS "operating profit" was $0.8m in FY2026, described as a $1.5m improvement on FY2025 (implying approximately -$0.7m in FY2025) [S3]. FY2024 income tax: FY2025-report comparative shows nil in the P&L while the tax note shows a $155k aggregate figure — an internal inconsistency in the FY2025 report that we flag rather than resolve [S2].
Margins and growth
Revenue CAGR: total revenue FY2023→FY2026 ≈ 67.7% p.a. (1.418 → 6.692; analyst calculation). Fee revenue FY2025→FY2026 +344% [S3].
Commentary — earnings quality inflection. FY2025 profit was driven overwhelmingly by fair-value gains ($4.39m), notably a $2.67m (356%) uplift on the $750k Revaia investment after its scrip acquisition by RegenCo, and Metal Powder Works gains [S2]. FY2026 profit was lower ($1.25m) but structurally better: fee revenue quadrupled, and unrealised unlisted gains fell from 53.1% to 16.2% of revenue [S1]. The decline in NPAT is explained by (i) $1.03m higher share-based payments, (ii) $0.96m higher variable people costs tied to advisory success fees, (iii) $0.59m higher recurring costs for the expanded team and full-year Aliwa, and (iv) $0.56m of FX losses and amortisation [S1]. The effective tax rate fell from 41.4% to 31.7% as the group qualified as a base-rate entity (25% rate) because passive income fell below 80% of assessable income — itself evidence of the revenue-mix shift [S1].
Balance sheet
Sources: FY2022 equity from HY2023 report comparative [S14]; FY2022 share count derived from market capitalisation ÷ share price in the remuneration table [S2]; FY2023 portfolio = 1 July 2023 opening balance [S2]; NTA [S13][S2][S1].
NTA methodology flag. Statutory net tangible assets per share (equity less intangibles ÷ shares) compute to ~9.4c (FY2025) and ~11.4c (FY2026). The company-reported 10.2c and 12.4c appear to add back deferred tax liabilities (i.e., a pre-tax NTA). Investors should treat the company figure as pre-tax NTA (analyst reconciliation; not stated explicitly in filings).
Commentary. The balance sheet is ungeared and asset-rich relative to market value but increasingly illiquid at the cash line: cash fell 54% in FY2026 to $1.09m, offset by $1.0m of Q4 success fees received in the September 2026 quarter and $4.69m of ASX-listed holdings [S1][S3]. Total "liquidity" (cash + treasury + listed) was $6.27m at 30 June 2026 vs $5.16m a year earlier [S1]. Level 3 assets (model-valued) rose to $6.06m from $4.02m.
Cash flow
FY2023 OCF from aggregator [S19] (not primary-verified).
Ratios
Net debt/EBITDA and interest coverage are not meaningful (net cash; no interest expense). Cash conversion cycle is not applicable to an investment/advisory business. Note InvestSMART reports FY2025 ROE of 11.3% on a different basis [S19].
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Country | Ownership (%) | Role |
|---|---|---|---|
Powerhouse Ventures Limited | Australia | Parent | Listed holding company; Treasury/Investing |
Powerhouse Advisory Australia Pty Ltd | Australia | 100 | Corporate Advisory business unit |
New River Asset Management Pty Ltd | Australia | 100 | AFSL No. 497505 holder; licensing platform |
Informed Investor Pty Ltd | Australia | 100 | Investor engagement/content website |
Aliwa Funds Management Pty Ltd | Australia | 100 | Manager of Aliwa Alpha Fund |
Powerhouse Venture Partners Pty Ltd (formerly Burleigh Venture Partners Pty Ltd) | Australia | 100 | Venture fund manager / business-building unit; investment manager to the CIO Fund CCIV |
RegenEarth Group Pty Ltd | Australia | 100 | Registered 18 Jul 2025; purpose not publicly detailed (likely linked to the carbon-projects theme — unconfirmed) |
Segment Overview
| Segment | Definition (company) | Contents |
|---|---|---|
Advisory | Corporate strategy execution support, commercial support and integrated corporate finance support | Powerhouse Advisory Australia; ECM raisings, IPOs, structured debt, sell-side M&A, mandates/retainers, corporate brokerage, AFSL fees |
Funds Management | Management of investment funds for wholesale clients | Aliwa Funds Management (Aliwa Alpha Fund); fund manager intangibles and goodwill |
Investing | Investing and treasury activities of the group | Listed and unlisted portfolio, treasury bonds, group overheads and share-based payments, income tax |
Revenue by Segment
| Segment | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Advisory revenue (AUD Mn) | 0 | 0.672 | 4.686 |
Funds Management revenue (AUD Mn) | 0 | 0.164 | 0.593 |
Investing revenue (AUD Mn) | 1.092 | 4.425 | 1.413 |
Total revenue as reported in segment note (AUD Mn) | 1.092 | 5.261 | 6.692 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment
| Segment | FY2025 | FY2026 |
|---|---|---|
Advisory Adjusted EBITDA (AUD Mn) | 0.349 | 3.336 |
Funds Management Adjusted EBITDA (AUD Mn) | -0.066 | 0.004 |
Investing Adjusted EBITDA (AUD Mn) | 3.516 | 0.285 |
Group Adjusted EBITDA (AUD Mn) | 3.799 | 3.625 |
Results by Segment — Advisory PBT
| Segment | FY2025 | FY2026 |
|---|---|---|
Advisory PBT (AUD Mn) | 0.349 | 3.336 |
Funds Management PBT (AUD Mn) | -0.066 | -0.164 |
Investing PBT (AUD Mn) | 2.817 | -1.340 |
Group PBT (AUD Mn) | 3.100 | 1.832 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2025 | FY2026 |
|---|---|---|
Advisory Adjusted EBITDA margin (%) | 52.0 | 71.2 |
Funds Management Adjusted EBITDA margin (%) | -40.4 | 0.6 |
Investing Adjusted EBITDA margin (%) | 79.5 | 20.2 |
Advisory share of group revenue (%) | 12.8 | 70.0 |
Funds Management share of group revenue (%) | 3.1 | 8.9 |
Investing share of group revenue (%) | 84.1 | 21.1 |
YoY growth FY2025→FY2026 | Value | — |
Advisory revenue growth | +597% (partly a half-year base effect) | — |
Funds Management revenue growth | +262% (first full year of Aliwa ownership) | — |
Investing revenue growth | -68% | — |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total revenue incl. investment gains (AUD Mn) | — | 1.418 | 1.092 | 5.322 | 6.692 |
Revenue from contracts with customers (AUD Mn) | — | — | 0.002 | 0.876 | 3.887 |
Net realised and unrealised investment gains (AUD Mn) | — | — | 0.929 | 4.387 | 2.784 |
Interest revenue (AUD Mn) | — | — | 0.161 | 0.059 | 0.021 |
Brokers' fees (AUD Mn) | — | — | 0 | 0.035 | 0.521 |
Net revenue after brokers' fees - gross profit proxy (AUD Mn) | — | — | 1.092 | 5.287 | 6.172 |
Employee benefits expense (AUD Mn) | — | — | 0.340 | 1.354 | 3.393 |
of which share-based payments total (AUD Mn) | — | — | 0.019 | 0.594 | 1.625 |
Total expenses (AUD Mn) | — | — | 0.687 | 2.222 | 4.861 |
Adjusted EBITDA - company definition (AUD Mn) | — | — | — | 3.799 | 3.625 |
Statutory EBITDA - PBT plus D&A (AUD Mn) | — | — | 0.405 | 3.205 | 2.000 |
Depreciation and amortisation (AUD Mn) | — | — | 0 | 0.105 | 0.168 |
Profit before tax (AUD Mn) | -0.286 | 0.717 | 0.405 | 3.100 | 1.832 |
Income tax expense (AUD Mn) | — | — | 0 | 1.282 | 0.581 |
Net profit after tax (AUD Mn) | -0.286 | 0.717 | 0.405 | 1.818 | 1.251 |
EPS basic (AUD cents) | — | — | 0.34 | 1.33 | 0.78 |
EPS diluted (AUD cents) | — | — | 0.34 | 1.11 | 0.65 |
Dividends per share (AUD cents) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Fee revenue share of total revenue (%) | — | 0.2 | 16.5 | 58.1 |
Statutory EBITDA margin (%) | — | 37.1 | 60.2 | 29.9 |
Adjusted EBITDA margin (%) | — | — | 71.4 | 54.2 |
Pre-tax margin (%) | 50.6 | 37.1 | 58.2 | 27.4 |
Net margin (%) | 50.6 | 37.1 | 34.2 | 18.7 |
Total revenue growth YoY (%) | — | -23.0 | 387.3 | 25.7 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | — | — | 11.164 | 18.658 | 23.410 |
Cash and cash equivalents (AUD Mn) | — | 3.039 | 2.440 | 2.386 | 1.089 |
Treasury investments (AUD Mn) | — | — | 0 | 0.436 | 0.490 |
Portfolio investments at fair value incl. treasury bonds (AUD Mn) | — | 7.626 | 8.549 | 14.309 | 18.955 |
Trade receivables and other current assets (AUD Mn) | — | — | 0.116 | 0.195 | 1.719 |
Goodwill and intangibles (AUD Mn) | — | — | 0 | 1.604 | 1.436 |
Total debt - short term (AUD Mn) | — | 0 | 0 | 0 | 0 |
Total debt - long term (AUD Mn) | — | 0 | 0 | 0 | 0 |
Net debt - negative equals net cash (AUD Mn) | — | -3.039 | -2.440 | -2.386 | -1.089 |
Total liabilities (AUD Mn) | — | — | 0.090 | 2.047 | 3.545 |
Deferred tax liabilities (AUD Mn) | — | — | 0 | 1.392 | 1.719 |
Total equity (AUD Mn) | 9.834 | 10.650 | 11.074 | 16.611 | 19.865 |
Working capital - current assets less current liabilities (AUD Mn) | — | — | 3.189 | 3.243 | 4.930 |
NTA per share - company reported (AUD cents) | 8.1 | 8.8 | 9.2 | 10.2 | 12.4 |
Shares on issue at year end (M) | 120.743 | 120.743 | 120.743 | 159.465 | 161.465 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | — | -0.39 | -0.543 | -0.797 | -0.846 |
Payments for investments - capex proxy (AUD Mn) | — | — | -0.794 | -4.497 | -2.185 |
Proceeds from disposal of investments (AUD Mn) | — | — | 0.799 | 3.404 | 1.535 |
Net investing cash flow (AUD Mn) | — | — | -0.055 | -1.133 | -0.650 |
Net equity raised (AUD Mn) | — | — | 0 | 1.876 | 0.200 |
Free cash flow - OCF less PP and E capex nil (AUD Mn) | — | -0.39 | -0.543 | -0.797 | -0.846 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Net change in cash (AUD Mn) | — | — | -0.598 | -0.054 | -1.297 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on year-end equity (%) | -2.9 | 6.7 | 3.7 | 10.9 | 6.3 |
ROA on year-end assets (%) | — | — | 3.6 | 9.7 | 5.3 |
ROIC - equals ROE as no debt (%) | -2.9 | 6.7 | 3.7 | 10.9 | 6.3 |
Current ratio (x) | — | — | 36.3 | 5.9 | 3.7 |
Debt to equity (x) | — | 0 | 0 | 0 | 0 |
Asset turnover - revenue over year-end assets (x) | — | — | 0.10 | 0.29 | 0.29 |
Revenue by Region and Revenue by Region (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
NZD-denominated investments (AUD Mn) | 3.096 | 2.803 | 2.368 |
USD-denominated investments (AUD Mn) | 1.379 | 1.691 | 2.111 |
Total foreign-currency investments (AUD Mn) | 4.475 | 4.494 | 4.480 |
Foreign-currency share of portfolio (%) | 52.3 | 31.4 | 23.6 |
Segment × Geography Details
| Segment × geography | FY2026 view |
|---|---|
Advisory | 100% Australian clients (ASX-listed and pre-IPO) |
Funds Management | Australian wholesale investors; ASX-listed holdings |
Investing | Australia (listed + unlisted), New Zealand (legacy university spin-outs such as Cirrus Materials, Inhibit Coatings, Ferronova, Veritide — domicile inferred from company history), United States (Aqur BioSciences, 6K Additive, Metal Powder Works heritage) |
Share Price and Market Valuation
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Share price at FY end (AUD) | 0.065 | 0.052 | 0.040 | 0.095 | 0.150 |
Market capitalisation (AUD Mn) | 7.848 | 6.279 | 4.830 | 15.149 | 24.220 |
P/E on statutory NPAT (x) | — | 8.8 | 11.9 | 8.3 | 19.4 |
P/B (x) | 0.80 | 0.59 | 0.44 | 0.91 | 1.22 |
Price to company-reported NTA (x) | 0.80 | 0.59 | 0.43 | 0.93 | 1.21 |
EV to total revenue (x) | — | 2.29 | 2.19 | 2.40 | 3.46 |
EV to adjusted EBITDA (x) | — | — | — | 3.36 | 6.38 |
Capital Markets
| Item | Status |
|---|---|
Analyst consensus | No broker research coverage identified |
Dividend history | No dividends paid, declared or recommended in FY2022–FY2026 [S1][S2] |
Dividend policy | Not formalised; FY2026 tax payment ($0.3m charge) noted as generating franking credits [S3] |
Credit ratings (Moody's/S&P/Fitch) | None (unrated; no debt) |
Debt maturity profile | Not applicable (no borrowings) |
Potential dilution | 21.5m performance rights (expiring Jan/Mar 2027), 4.0m unlisted options ($0.10–$0.18 strikes, expiring Feb/Mar 2027), 6.38m Aliwa earn-out shares issued/issuable post year-end [S1] |
Liquidity | Average daily volume ~180–210k shares in 2024–25 per aggregators (thin) |
Analyst Conclusions
Management guidance and expectations
There is no numeric FY2027 earnings guidance. Management's stated agenda is to "compound" the FY2026 position, grow FUM (Aliwa raise targeting a soft close in FY2027; CIO Fund $75m target; European co-managed fund ~$100m), scale Advisory using existing distribution and systems, and launch PVP products beginning with SPV1 [S1][S3][S9]. No sell-side consensus exists.
Bull case
-
Earnings quality is genuinely improving. Fee revenue now accounts for 58.1% of total revenue (from 0.2% two years earlier), Advisory runs at a ~71% adjusted EBITDA margin, and the group reached a maiden company-defined operating profit without raising equity [S1][S3].
-
Asset-backed downside with optionality. At ~1.2x company-reported NTA and zero debt, investors pay a modest premium for a $19m portfolio plus three fee businesses; a single successful exit (e.g., Southern Launch, Liquid Instruments) or CIO Fund raise could re-rate NTA and recurring revenue simultaneously.
-
Funds platform leverage. Each $10m of new FUM adds recurring management fees at minimal incremental cost; the CIO Fund and global fund targets would multiply FUM several-fold if achieved, and Aliwa's top-decile performance supports raising.
Bear case
-
Cash, not accruals, is the constraint. Operating cash flow has been negative every year reviewed, cash fell to $1.09m, and 53% of advisory revenue is earned in micro-cap scrip whose realisable value depends on market liquidity [S1][S3].
-
Governance and cost structure. An all-executive three-person board with no committees approves its own remuneration ($2.65m KMP cost vs $1.25m NPAT), related-party transactions and investee-board appointments [S1].
-
Cyclical and opaque earnings. HY2026 NPAT fell 46.6%; the Mar 2026 quarter showed an 8.7% fund drawdown and 6% NTA decline; $6.1m of Level 3 assets rely on model inputs [S4][S7][S1].
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable |
|---|---|
| Late Oct 2026 | Q1 FY2027 Appendix 4C: collection of $1.0m Q4 success fees; operating cash flow sign; NTA |
| Oct–Nov 2026 | Notice of AGM and AGM (14 Nov 2026): name-change resolution status, remuneration vote, any board renewal |
| FY2027 | CIO Fund capital raised versus $75m target; Aliwa soft close and FUM above $31.5m |
| FY2027 | SPV1 launch and first PVP fee-paying engagements |
| CY2026–27 | European co-managed fund conversion from MOU to launch |
| Jan–Mar 2027 | Performance-rights observation dates (vesting and dilution) |
| Feb 2027 | HY2027 results: advisory revenue run-rate, share-based-payment normalisation |
| Ongoing | Liquidity events in Southern Launch, Liquid Instruments, Quantum Brilliance; recovery or further write-downs in Urbix, Cirrus, Inhibit, Revaia |
Analyst verdict
Powerhouse Ventures has executed one of the more complete business-model pivots on the ASX micro-cap board. In under three years a New Zealand university-IP incubator that had accumulated roughly $24m of losses has become a Brisbane-based merchant bank whose fee businesses generated $3.89m of revenue in FY2026, with Advisory alone producing $3.3m of segment EBITDA at a 71% margin. NTA per share has risen for four consecutive years, the balance sheet carries no debt, and the flagship Aliwa fund ranked second of 100 peers. These are tangible, audited achievements, not narrative.
The investment case, however, rests on three unresolved tensions. First, accounting profit has not yet become cash: operating cash flow remains negative, cash has fallen to about $1.1m, and over half of advisory fees arrive as micro-cap scrip. Second, governance is unusually thin for a listed entity managing third-party money — three executive directors, no independent oversight, related-party acquisitions and investee directorships, and executive pay that exceeded twice NPAT in FY2026. Third, the growth plan depends on raising external capital into new vehicles (CIO Fund, SPV1, a European co-managed fund) whose targets dwarf the group's current $31.5m FUM and whose progress has not yet been quantified.
At around 1.2x company-reported NTA and ~6x adjusted EBITDA (30 June 2026 basis), the market is paying a modest premium for the operating platform. That looks reasonable if FY2027 delivers positive operating cash flow, demonstrable third-party inflows into the new funds, and at least one independent director appointment. Absent those, the stock remains a high-beta proxy for ASX micro-cap sentiment with significant key-person and governance risk. Overall stance: speculative, catalyst-dependent; constructive on operating momentum, cautious on cash conversion and governance. This assessment is analytical and not personal financial advice.
End of dossier. All figures AUD unless stated; fiscal years end 30 June.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Tenure | Background / education | Other directorships (last 3 years) | Shares held | Performance rights |
|---|---|---|---|---|---|---|
James Kruger | Executive Chairman (also CODM) | — | B.Com, LLB, BA (University of Queensland); Master of Applied Finance (Macquarie University); 20+ years global career at Macquarie Group; deep-tech and energy-transition investor | Lava Blue (to Jul 2024), Boomarra Minerals (to Mar 2025), Halocell alternate (to Nov 2025); NED of portfolio companies VeriQuantix and Sirius Beta Labs | 2,395,513 | 4,500,000 |
David McNamee | Executive Director; Portfolio Manager, Aliwa Funds Management; named CIO of the CIO Fund | Appointed 26 Mar 2024 | Founder of Aliwa Funds Management; micro-cap investor | NED Regenco Limited (portfolio company) | 26,815,550 (incl. 5.6m earn-out shares issued 17 Jul 2026) | 4,500,000 |
Doron Eldar | Executive Director; named Portfolio Manager of the CIO Fund | Appointed 10 Jul 2024 | BA Business Economics; partner at SIBF (Israeli VC); tech entrepreneur | Dotz Nano (NED), Electriq Global (Director; portfolio company), Energy Technologies Ltd (from Jan 2026) | 3,809,778 | 4,500,000 |
Executive Leadership Team
| Name | Role | Since | Background |
|---|---|---|---|
Geoffrey Nicholas | Chief Financial Officer; Company Secretary from 9 Jul 2026 | KMP since at least FY2024 | B.Bus (Accounting), Swinburne; CPA; 20+ years senior finance |
Richard Rouse | Head of Advisory | 21 Feb 2025 | Not detailed in filings |
Michael Datta | Strategic Growth Partner, PVP (not KMP) | 8 Oct 2026 | Founding Director, Noosa Partners; 30 years building/exiting businesses |
Directors' Remuneration
| Name | Cash salary/fees | Cash bonus & commissions | Post-employment | Share-based payments | Total FY2026 | Total FY2025 |
|---|---|---|---|---|---|---|
James Kruger | 120,000 | 72,000 | 0 | 160,426 | 352,426 | 202,452 |
David McNamee | 222,030 | 0 | 21,000 | 626,990 | 870,020 | 399,927 |
Doron Eldar | 74,400 | 227,850 | 0 | 289,155 | 591,405 | 239,936 |
Richard Rouse | 99,996 | 284,456 | 0 | 112,832 | 497,284 | 78,838 |
Geoffrey Nicholas | 160,000 | 54,000 | 0 | 125,830 | 339,830 | 170,659 |
Total KMP | 676,426 | 638,306 | 21,000 | 1,315,233 | 2,650,965 | 1,207,952 |
Directors' Remuneration by Attribute
| Attribute | Status |
|---|---|
Board size | 3 |
Independent directors | 0 (all executive) |
Chair/CEO separation | No CEO role; Executive Chairman acts as Chief Operating Decision Maker |
Committees | None; full board discharges audit, risk, nomination and remuneration functions because board has fewer than four members [S1] |
Gender diversity (board) | 0% women |
Board meetings FY2026 | 15 held; Kruger 14, McNamee 14, Eldar 13 attended [S1] |
Related-party features | Aliwa acquisition from a director (approved under Listing Rule Chapter 10, Nov 2024); directors sit on boards of investee companies (Regenco, Electriq Global, VeriQuantix, Sirius Beta Labs) in which PVL invested during FY2026 [S1][S2] |
Remuneration report vote | 100.00% for at 14 Nov 2025 AGM; 99.99% at Nov 2024 AGM [S1][S2] |
Major Shareholders
| Holder | Shares | Approx. stake (%) |
|---|---|---|
David McNamee (and related parties) | 26,815,550 | 16.0 |
Geoffrey Nicholas | 4,650,000 | 2.8 |
Doron Eldar | 3,809,778 | 2.3 |
James Kruger | 2,395,513 | 1.4 |
Richard Rouse | 2,300,000 | 1.4 |
Insiders total | 39,970,841 | 23.8 |
Competitive Landscape
Competitors by Segment
| Arena | Competitor | Listing | Relative positioning vs PVL |
|---|---|---|---|
Advisory / ECM | Euroz Hartleys Group | ASX:EZL | Far larger full-service WA broker with research and wealth arms |
Advisory / ECM | Bell Financial Group | ASX:BFG | National broker with large retail/institutional distribution |
Advisory / ECM | Canaccord Genuity (Australia) | Private (TSX parent) | Mid-market ECM leader in resources |
Advisory / ECM | Morgans Financial | Private | Large retail network; frequent micro-cap lead manager |
Advisory / ECM | Shaw and Partners | Private | Strong ECM franchise in small caps |
Advisory / ECM | Taylor Collison, Henslow, Barclay Pearce Capital, Evolution Capital, Argonaut | Private | Direct boutique competitors for sub-$250m issuers |
Advisory / investor media | Sequoia Financial Group | ASX:SEQ | Also a partner/shareholder; broader wealth/licensee services |
Funds management (micro-cap) | K2 Asset Management | ASX:KAM | Listed boutique manager; materially larger AUM |
Funds management (micro-cap) | Numerous wholesale micro-cap funds ranked by FundMonitors.com | Private | Aliwa ranked 2nd of 100 in FY2026 |
Listed tech investment vehicles | Bailador Technology Investments | ASX:BTI | Larger, growth-stage tech portfolio |
Listed tech investment vehicles | Thorney Technologies | ASX:TEK | Listed tech investor |
Deep-tech venture | Main Sequence Ventures; Uniseed; Blackbird Ventures | Private | Larger pools; university/CSIRO-linked deep-tech competition |
Competitor Detail
| Metric (FY2026 unless stated) | PVL |
|---|---|
Revenue (AUD Mn) | 6.69 (fee revenue 3.89) |
Revenue growth (%) | 25.7 (fee +344) |
Adjusted EBITDA margin (%) | 54.2 |
Net margin (%) | 18.7 |
R&D intensity (%) | 0 (not applicable) |
Balance-sheet co-investment model | Core |



